AE Wealth Management LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
AE Wealth Management LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q4 2020$83,000
+50.9%
20,766
+2.5%
0.00%0.0%
Q3 2020$55,000
-1.8%
20,2660.0%0.00%0.0%
Q2 2020$56,000
-3.4%
20,266
-18.2%
0.00%0.0%
Q1 2020$58,000
-50.4%
24,786
-0.1%
0.00%
-66.7%
Q4 2019$117,000
+9.3%
24,814
-22.4%
0.00%0.0%
Q3 2019$107,000
+9.2%
31,983
+7.9%
0.00%0.0%
Q2 2019$98,00029,6500.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 1,820,524$4,697,0003.00%
ARMISTICE CAPITAL, LLC 12,050,000$31,089,0002.03%
Broadfin Capital, LLC 4,623,247$11,928,0001.88%
Healthcare Value Capital, LLC 100,000$258,0000.73%
Healthcare Value Capital, LLC 100,000$258,0000.73%
MYCIO WEALTH PARTNERS, LLC 2,433,500$6,278,0000.65%
PERKINS CAPITAL MANAGEMENT INC 317,500$819,0000.59%
Brown Advisory Securities, LLC 275,000$710,0000.12%
FALCON POINT CAPITAL, LLC 222,501$574,0000.11%
Avenir Corp 291,597$752,0000.09%
View complete list of ANTARES PHARMA INC shareholders